Glancy Binkow & Goldberg LLP announces that it is investigating potential claims against the Board of Directors of Venoco Inc. ("Venoco" or the "Company") (NYSE: VQ) related to the proposed acquisition of the Company by Venoco's CEO and Chairman, Timothy Marques. The transaction is valued at approximately $382 million or $12.50 per share.

The investigation concerns whether the Board of Directors of Venoco breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction. The Company's shares have traded as high as $22.22 as recently as February 2, 2011. Further, at least one analyst has set a target price for the Company's stock at $22.00.

If you are a shareholder of Venoco, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Louis Boyarsky, Esquire, Glancy Binkow & Goldberg LLP, 1801 Avenue of the Stars, Suite 311, Los Angeles, CA 90067, by telephone at (310) 201-9150 or Toll Free at (888) 773-9224 or by email to shareholders@glancylaw.com.

Glancy Binkow & Goldberg LLP
Louis Boyarsky, Esquire
310-201-9150
Toll Free 888-773-9224
shareholders@glancylaw.com